Logo
About the Cancer Registry of Norway
About the Cancer Registry of Norway
  • The Registries
    • Cancer Statistics
    • Data and statistics
      • Statistics online
    • Clinical registries
      • The Professional Council of the Quality Registers
      • National Colorectal Cancer Registry
        • Quality measurements for the Colorectal Cancer Registry
        • The Colorectal Cancer Registry's advisory board
        • Resultater fra Tykk- og endetarmskreftregisteret
        • Degree of coverage and data quality in the Colorectal Cancer Registry
      • Norwegian Breast Cancer Registry
        • Degree of coverage and data quality for the Breast Cancer Registry of Norway
        • Quality objectives for the Breast Cancer Registry of Norway
        • The Breast Cancer Registry's Professional Council
        • Resultater fra Brystkreftregisteret
      • Norwegian Childhood Cancer Registry
        • Degree of coverage and data quality in the Childhood Cancer Registry of Norway
        • Quality objectives for the Childhood Cancer Registry
        • The Norwegian Childhood Cancer Registry's advisory board
        • Resultater fra barnekreftregisteret
      • Norwegian Gynecological Cancer Registry
        • Coverage and data quality for the Gynecological Cancer Registry
        • Quality objectives for the Gynecological Cancer Registry
        • Gynecological Cancer Registry's Advisory Council
        • Resultater fra Gynekologisk kreftregister
      • Norwegian Lung Cancer Registry
        • Publiserte artikler fra Spesialregister for lungekreft
        • Coverage and data quality for the Lung Cancer Registry
        • Quality measurements for the Lung Cancer Registry of Norway
        • The Lung Cancer Registry's Advisory Council
        • Results from the Lung Cancer Registry of Norway
      • Norwegian Melanoma Registry
        • Melanoma coverage and data quality
        • Quality measurements for the Melanoma Register
        • The Melanoma Register Professional Council
        • Resultater fra Melanomregisteret
      • Norwegian Pancreatic Cancer Registry
        • The Advisory Council of the Pancreatic Register
        • Degree of coverage and data quality
        • Resultater
      • Norwegian Prostate Cancer Registry
        • Quality objectives for the Prostate Cancer Registry
        • The Prostate Cancer Registry's advisory board
        • Resultater fra prostatakreftregisteret
        • Coverage and data quality in the Prostate Cancer Registry
      • Norwegian registry of brain and spinal cord tumours
        • Fagrådet
        • Resultater fra Kvalitetsregister for hjerne- og ryggmargssvulster
        • Degree of coverage and data quality
      • Norwegian Registry of Lymphoid Malignancies
        • Degree of coverage and data quality for the Norwegian Registry for Lymphoid Malignancies
        • Quality measure for the Norwegian Registry for Lymphoid Malignancies
        • Advisory Council of the National Registry of Lymphoid Malignancies
        • Resultater fra Register for lymfoide maligniteter
      • Norwegian Registry of Oesophagus and Stomach Cancer
        • Degree of coverage and data quality
        • Academic Council
        • Resultater
      • Norwegian Sarcoma Cancer Registry
        • Academic Council
        • Degree of coverage and data quality
        • Quality measurements for the Sarcoma Registry
        • Resultater
    • Reporting
      • Electronic Notification Service
      • Notifiable diagnoses
      • Functionality in KREMT
      • Further development in KREMT
      • KREMT helpdesk
      • Contact persons - reminders
      • Development projects - reporting
      • Notification form for paper reporting
      • Reporting - pathology
    • NORDCAN
  • Research
    • News & Events
      • RNA forum
    • Departments and reseachers
      • Section for Molecular Epidemiology and Infections
      • The Section for Analysis and Research
      • Section for administration and research support
      • Section for Epidemiology and Prevention
    • Projects
      • Development of AI algorithms in BreastScreen Norway
      • Artificial intelligence in BreastScreen Norway - a randomized controlled trial
      • Asbestoscement and cancer risk
      • BADDI: Artificial intelligence in screening with standard mammography and tomosynthesis
      • Brain tumor among children and adolescents
      • Advantages and disadvantages of artificial intelligence in BreastScreen Norway
      • Can we apply new methods to better follow up HPV-positive women?
      • Cancer among Norwegian offshore workers
        • Receivement and use of register data from the oil companies
        • Instruksjonsvideo heliport
        • I can't get through to “postens signeringstjeneste”
        • I get the message "Bank ID needs to access cookies" (iPhone)
        • I cannot find the “sign document” button in “postens signeringstjeneste”
        • I get a system error message when I try to log in with my Bank-ID
        • I have signed the consent, but cannot get through to the questionnaire
        • I am not sure if my answer was delivered
        • I want to withdraw my consent
        • Chemical exposure, night shift work and cancer risk among Norwegian offshore workers
        • Exposure-related risks of cancer in petroleum workers
        • Cancer risk after benzene exposure
        • Cohorts of offshore workers
        • Common problems when logging in and signing the consent
        • Academic collaborators
        • Financial research support
        • Survey among offshore workers
        • Background and aim
        • Employees in the offshore group
        • Projects of the offshore group
        • Research dissemination
        • Collaborators and financial research support
      • Cancer and pregnancy
      • Cancer patient pathways in Norway
      • Cancer risk among agricultural workers
      • Firefighters and cancer
        • Annual meeting with the professional reference group
      • Cardiac catheterization of children with congenital heart defects
      • Cost and treatment for patients with lung cancer
      • Course of disease in bladder cancer patients
        • Behandling av muskelinfiltrerende blærekreft
      • COVID-19 and cancer in the Nordic countries
      • CT examination of children and the risk of cancer (EPI-CT)
      • Drug use and cancer
        • Medications and Cancer
        • Mapping of drugs and cancer
      • Prescription drugs and cutaneous melanoma
      • Effectiveness of tomosynthesis in breast cancer screening
      • EULAT Eradicate Gallbladder Cancer
      • Gene activity in testicular cancer
      • How quickly do breast cancers grow?
      • Sequencing HPV for biomarker discovery
        • Intra-patient HPV genetic variation
        • HPV genomic workshop
      • HPV-related research
        • Om studien
        • Langtidseffekt av screening mot livmorhalskreft
        • Personalised cervical cancer screening
        • Regionale forskjeller i livmorhalskreft i Norge
        • Tidlig vaksinasjonseffekt: kjønnsvortetrender i Norge
        • Livmorhalskreft blant unge kvinner
        • Can we apply new methods to better follow up HPV-positive women?
        • Self-collected specimens in the fight against cervical cancer
        • Sylinderepitelforandringer i livmorhalsen og risiko for livmorhalskreft
        • Uønskede svangerskapsutfall etter behandling av forstadier til livmorhalskreft
        • Prognostiske markører for differensiering av kvinner med høy og lav risiko for utvikling av livmorhalskreft
        • Celleprøvetaking fra livmorhalsen (cervix) - er det så vanskelig?
        • Adenocarsinoma in situ i cytologisk prøve skal behandles
        • Fatal livmorhalskreft opp mot screeningdeltakelse og alder hos norske kvinner
        • Biomarkers for HPV-related cancers
        • Effects of HPV vaccination in Norway
        • EQUALSCREEN – INCREASED ATTENDANCE AND REDUSED INEQUITY IN CERVICAL CANCER SCREENING
        • Prevalence of human papillomavirus (HPV) among the population
        • Forekomst av HPV-typer blant kvinner med forstadier og livmorhalskreft
        • HPV-vaksinering og screening blant kvinner født 1975-1996
        • Kvinners livsstil og helse - forskning på livsstil, virus og kreft
      • ImmigrantScreen
      • Impact of vitamin D and obesity on bladder cancer; Risk and survival
      • Innovative commitment to action against cancer (iPAAC)
      • INSPIRE - information about drug cancer treatment
        • INSPIRE:lung cancer
        • INSPIRE: Breast cancer
        • Publications from INSPIRE
        • INSPIRE:kidney cancer
      • JanusRNA - identification of early cancer biomarkers
        • Biomarkers of Cancer: Biocomputional analysis of data from population-based biobanks and health registries
        • Bakgrunn og formål
        • Data
        • Publikasjoner
        • Prosjektgruppen
        • Samarbeidspartnere og finansiering
        • JanusRNA delprosjekter
        • JanusRNA - identification of early cancer biomarkers
      • Largyngeal Papillomatosis / Recurrent Respiratory Papillomatosis (RRP)
        • Largyngeal papillomatose / Recurrent Respiratory Papillomatosis (RRP)
        • Deltakerinformasjon
        • Bli kjent med prosjektgruppen
        • Finansiering og samarbeid
        • Forskningsformidling
        • Background and objective
        • Participant information
        • Meet the research group
        • Financing and collaborations
        • Publications
      • Lifestyle changes and future health
      • Long-term effects following treatment of screen-detected versus symptomatic breast cancer
      • LTFU: Long-term follow up of subjects participating in the clinical trials of the HPV-vaccine
        • Blodprøvetaking i "Utvidet langtidsoppfølging av deltakere i studien med vaksine mot livmorhalskreft" LTFU studien
        • Financing
        • Collaborations
        • LTFU V501: Extended Long-Term Follow-Up of Women Participating in the Cervical Cancer Vaccine Study (FUTURE II)
        • LTFU V503: Long-Term Follow-Up of Women Participating in the Phase III Clinical Trial with the 9-valent HPV Vaccine
        • Publications
        • Media and dissemination
        • Participant information V501
        • Participant information V503
        • Long-Term Follow-Up (LTFU) of Nordic Women Participating in Early Studies of Cervical Cancer Vaccines
        • Research projects
        • Participant information
        • Research group
        • Financing and collaborations
        • Research dissemination
      • The microbiome as a colorectal cancer screening biomarker (CRCbiome)
        • Sammenheng mellom bearbeidet mat og tarmkreft
        • Mikrobiella biomarkører - NORCCAP
        • Deltakerinformasjon CRCbiome
        • Masterprosjekter
      • New cancer treatment and survival
        • Immunotherapy and targeted therapy of advanced non-small cell lung carcinoma
        • New cancer treatment and survival: prostate cancer
        • Ny kreftbehandling og overlevelse: føflekkreft
      • Nordpred: Prediction of cancer incidence in the Nordic countries up to the year 2020
        • Nordpred software package
      • A randomized study on colorectal cancer screening (NORCCAP)
        • NORCCAP - Ph.D theses
        • NORCCAP - publications
        • Rådgivingsgruppe NORCCAP-biobank
      • Using the OMOP data model
        • FLORENCE: Federated Learning on Cancer Data
        • FLORENCE: føderert læring på kreftdata
        • BlueBerry
        • Andre OMOP prosjekter
        • Blueberry
        • Other OMOP projects
        • Dissemination
        • Collaborators
        • AI solution for use in cancer operations under the EU program Interreg ØKS
        • Samarbeidspartnere
        • Using the OMOP datamodel
        • Research projects
        • OMOP EHDEN project: CRN maps its core variables to OMOP CDM
        • Bruk av datamodellen OMOP
        • Forskningsprosjekter
        • Forskningsformidling
      • Patient reported outcomes after treatment for colorectal cancer – A prospective nationwide study from The Norwegian Colorectal Cancer Registry
      • Personalizing colorectal cancer screening by lifestyle
      • Physical activity, fitness and cancer
      • Prescribed drugs and cutaneous melanoma
      • Research on environmental toxins and cancer
      • SARS-CoV-2 in cancer patients
      • Stress management after breast cancer (SEB)
        • For deltakere: Stressmestring etter brystkreft
        • Spørsmål og svar
      • Terminated projects
        • Hva vil undersøkelsen omfatte?
        • Hva skal gjøres i prosjektet, og er det laget en tidsplan?
        • Vil det bli gjort medisinske undersøkelser på de som ikke har konstatert kreft i dag, naboer eller tidligere raffineriansatte?
        • Hva bør man gjøre dersom man er bekymret for helsen (kreftrisiko)?
        • Hvorfor er personer som ikke er naboer eller tidligere raffineriansatte, men som har eller har hatt arbeidsplass i nærheten av raffineriet, ikke med i undersøkelsen?
        • Er sektorene for dominerende vindretninger og antatt nedslagsfelt, slik de har vært presentert i media riktig?
        • Vil undersøkelsen kun basere seg på tall og statistisk materiale?
        • Kommer naboer til å bli invitert til å delta i undersøkelsen, f.eks. ved intervju? Når vil det i så fall skje?
        • Hvem sitter i ressursgruppa?
        • Ser man i denne undersøkelsen etter alle, eller spesifikke krefttyper, og i så fall hvilke krefttyper ser man etter?
        • Hvilke krefttyper er dette (se spørsmål over)?
        • Hvordan kan man skille mellom kreft pga arv, gener, livsstil og annen eksponering, og kreft pga raffineriet?
        • Hvilke konklusjoner har man fra andre undersøkelser knyttet til sammenhengen mellom kreft og raffineri-virksomhet?
        • Status per 31. oktober 2008
        • Ofte stilte spørsmål
        • Information for participants in the project "Cancer risk among nurses"
        • Fight HPV and Cervical Cancer
        • miRNA signaturer i pasienter med kreft i tykktarm, bryst og lunge
        • Social inequality and HPV vaccination
        • SVEIP: Effect of School based HPV-vaccination in the population
        • Does Gardasil cause birth defects?
        • Sola-prosjektet (Fullført 2009)
        • What prevents women from taking cervical pap smear?
        • Improving the mass screening for cervical cancer
        • Fight HPV and Cervical Cancer
        • Why do some precancerous lesions develop into cervical cancer?
        • Cancer risk of preinvasive adenocarcinoma
        • EQUALSCREEN – INCREASED ATTENDANCE AND REDUSED INEQUITY IN CERVICAL CANCER SCREENING
        • Penile cancer
        • Cancer risk among nurses
        • Overdiagnosis and underdiagnosis in BreastScreen Norway
        • How likely are benign breast disease and premalignant lesions to progress to invasive breast cancer?
        • Breast compression in BreastScreen Norway
      • Testicular cancer and heredity
      • The impact of obesity and circulating small RNA in the development of endometrial cancer
      • Tomosynthesis – the future screening tool for breast cancer?
      • Vitamin D and cancer prognosis
      • Vitamin D, obesity and cutaneous malignant melanoma
    • Scientific publications
      • List of publications 2016
        • Under 30 forfattere
        • Over 30 forfattere
      • List of publications 2015
        • Artikler under 30 forfattere
        • Artikler over 30 forfattere
      • List of publications 2014
      • List of publications 2013
      • List of publications 2012
      • List of publications 2011
      • List of publications 2010
      • List of publications 2009
      • List of Publications 2008
      • Published articles 2017
        • First and/or last author
        • All published articles 2017
      • Published articles 2018
        • First and/or last author
        • All published articles
      • Published articles 2019
        • first and/or last author
        • All published articles
      • Published articles 2020
        • All published articles
        • First and/or last author
      • Published articles 2021
      • Published articles 2022
      • Published articles 2023
    • Janus Serum Bank
      • About Janus serum bank
        • Articles of association
      • For participants
      • For researchers
        • Quality assurance
        • How to apply for biological material and data from the Janus serum bank
        • Terms and conditions for use of biological material and data from the Janus serum bank
      • The Janus material
      • Research activities
      • Published articles
  • Screening
    • About the Screening Programmes
    • BreastScreen Norway
      • Breast Cancer Screening Programme
        • About the programme
        • Ofte Stilte Spørsmål
        • Samtykke
      • The screening mammogram
      • Benefits and harms
        • Diskusjon om nytteverdi
        • Om beregninger for brystkreftdødelighet og overdiagnostikk
        • More information about advantages and disadvantages of breast cancer screening
        • EU-TOPIA
      • Information resources in BreastScreen Norway
      • Breast centres
      • Translations
        • Information in Polish
        • Information in Urdu
        • Information in English
        • Information in Arabic
        • Information in Somali
        • Northern Sami
        • Ukrainian
      • Why the age group 50-69 years?
      • European guidelines
      • Organization
        • Helseforetak i Mammografiprogrammet
      • Research in BreastScreen Norway
      • Quality assurance and quality improvement
        • BERM: Bedre Radiografi i Mammografiprogrammet
      • Film: How mammography takes place
    • Cervical Cancer Screening in Norway
      • Letters
      • Self-sampling in Cervical Screen Norway
      • Frequently asked questions
        • Hva er konisering?
        • Hva er HPV hjemmetest?
        • Slik tar du livmorhalsprøven
        • How often should I take a cervical test?
        • Symptoms
        • Hva er livmorhalskreft?
        • Informasjon om celleforandringer
        • The PAP test
        • HPV Vaccine
        • HPV
      • Benefits and harms of screening
      • Primary HPV test - now also for women under 34
        • Information for women about HPV test in CervicalScreen Norway
        • I'm HPV positive - now what?
        • Status for implementering av HPV-test
      • Reservation
        • Nå kan Livmorhalsprogrammet dele prøvehistorikk
      • Vaccine
      • Cervical Cancer Screening Programme
      • Translations
        • Informasjon på somalisk
        • Litausk
        • Informasjon på urdu
        • Information in Polish
        • Oversettelser til engelsk/English translations
        • Informasjon på ukrainsk
    • ColorectalScreen Norway
      • Invited to screening?
        • What is screening?
        • Pros and cons
      • When will the screening program be available for you?
      • Cancer prevention
      • What is Colorectal cancer ?
      • Research
      • Privacy
      • Information in the program
  • Employees
  • Vacant positions
  • Media
  • Strategy
  • Data and statistics
  • Cancer in Norway
  • Publications
  • Personvern
  • Key figures on cancer
  • Cancers
About the Cancer Registry of Norway
    • The Registries

      • Cancer Statistics
      • Data and statistics
      • Clinical registries
      • Reporting
      • NORDCAN
    • Research

      • News & Events
      • Departments and reseachers
      • Projects
      • Scientific publications
      • Janus Serum Bank
    • Screening

      • About the national screening programmes
      • BreastScreen Norway
      • CervicalScreen Norway
      • ColorectalScreen Norway
      • Employees
      • Data and statistics
      • Key figures on cancer
      • Vacant positions
      • Cancer in Norway
      • Cancers
      • Media
      • Publications
      • Strategy
      • Personvern
/
Research News & EventsSections and researchersProjectsPublicationsJanus Serum Bank
/
Projects AI algorithms in BreastScreen NorwayAIMSAsbestoscement and cancer riskBADDIBrain tumor among children and adolescentsCan artificial intelligence increase accuracy and effectiveness of breast cancer screening?Can we apply new methods to better follow up HPV-positive women?Cancer among Norwegian offshore workers in NorwayCancer and pregnancyCancer patient pathways in NorwayCancer risk among agricultural workersCancer risk among firefightersCardiac catheterization of children with congenital heart defectsCost and treatment for patients with lung cancerCourse of disease in bladder cancer patientsCOVID-19 and cancer in the Nordic countriesCT-undersøkelse av barn og risiko for kreft (EPI-CT)Drug use and cancerDrugs and prognosis for melanomaEffectiveness of digital breast tomosynthesis in population breast cancer screeningEULAT eradicate GBCGene activity in testicular cancerHow quickly do breast cancers grow?HPV sequencingHPV-related researchImmigrantScreenImpact of vitamin D and obesity on bladder cancer; Risk and survivalInnovative commitment to measures against cancerINSPIREJanusRNA - identification of early cancer biomarkersLaryngeal papillomatose / Recurrent Respiratory PapillomatosisLifestyle changes and future healthLong-term quality of life after breast cancer treatmentLTFUMicrobiota and lifestyle in Colorectal Cancer ScreeingNew cancer treatment and survivalNordpredNorwegian Colorectal Cancer Prevention studyOMOP projectsPatient reported outcomes after treatment for colorectal cancer – A prospective nationwide study from The Norwegian Colorectal Cancer RegistryPersonalizing colorectal cancer screening by lifestylePhysical activity, cardiorespiratory fitness and cancerPrescribed drugs and cutaneous melanomaResearch on environmental toxins and cancerSARS-CoV-2 in cancer patientsStress management after breast cancerTerminated projectsTestikkelkreft og arvThe impact of obesity and circulating small RNA in the development of endometrial cancerTomosynthesis-studies-in-BergenVitamin D (calcium, albumin and PTH) and cancer prognosisVitamin D, obesity and cutaneous malignant melanoma
/
OMOP projects CollaboratorsDissemination Research projects Background and aimOMOP EHDENAI solution for use in cancer operations
/
Research projects Other OMOP projectsBlueberryFLORENCE: Federated Learning on Cancer Data
Institute text

Other OMOP projects

Arrow to top
To the top
Institute text

Cancer Registry of Norway

 

Support

Telephone switchboard
22 45 13 00
09.00-14.30


Read more

Information about the Cancer Registry of Norway
Employees
Vacancies
Contact
Press


Information

The Cancer Registry of Norway uses cookies
Privacy statement
Avaliaibility statement

Logo